Conditional Reprogramming Modeling of Bladder Cancer for Clinical Translation.
Daneshdoust D, Yin M, Luo M, Sundi D, Dang Y, Lee C, Li J, Liu X.
Daneshdoust D, et al.
Cells. 2023 Jun 24;12(13):1714. doi: 10.3390/cells12131714.
Cells. 2023.
PMID: 37443748
Free PMC article.
Review.
Predictive tools to select patients who will be responsive to invasive or morbid therapies (chemotherapy, radiotherapy, immunotherapy, and/or surgery) are largely absent. Patient-derived and clinically relevant models including patient-derived xenografts (PDX), organoids, …
Predictive tools to select patients who will be responsive to invasive or morbid therapies (chemotherapy, radiotherapy, immunotherapy, and/o …